Impact of the 2018 HER2 Testing Focused Update on Classification of dual-probe ISH Groups

被引：0
|
作者：
Schmolze, Daniel [1 ]
Apple, Sophia [2 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
249
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of the updated 2018 ASCO/CAP guidelines for HER2 testing in breast cancer
    Li, Anqi
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [22] Impact of the updated 2018 ASCO/CAP guidelines for HER2 testing in breast cancer
    Li, Anqi
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    MODERN PATHOLOGY, 2019, 32
  • [23] HER2 testing in the MOUNTAINEER trial: Analysis of treatment response based on central HER2 assessment using IHC/ISH and NGS
    Strickler, John H.
    Cercek, Andrea
    Ng, Kimmie
    Siena, Salvatore
    Andre, Thierry
    Van Cutsem, Eric
    Wu, Christina
    Paulson, Andrew Scott
    Hubbard, Joleen M.
    Coveler, Andrew L.
    Fountzilas, Christos
    Kardosh, Adel
    Kasi, Pashtoon Murtaza
    Lenz, Heinz-Josef
    Ciombor, Kristen Keon
    Elez, Elena
    Stecher, Michael
    Cronin, Pauline
    Bieda, Mark
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Impact of 2013 HER2 Testing Guideline Update on FISH Interpretation and HER2-Targeted Therapy Eligibility
    Singh, M.
    Sophian, A.
    Almanaseer, I.
    Pins, M.
    August, C.
    Mihalov, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 752 - 753
  • [25] Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (D-ISH) in the determination of HER2 status
    Mansfield, A. S.
    Sakai, Y.
    Walsh, F. J.
    Wiktor, A. E.
    Sukov, W. R.
    Dogan, A.
    Jenkins, R. B.
    CANCER RESEARCH, 2012, 72
  • [26] A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay
    Bartlett, J. M. S.
    Campbell, Fiona M.
    Ibrahim, Merdol
    O'Grady, Anthony
    Kay, Elaine
    Faulkes, Catherine
    Collins, Nadine
    Starczynski, Jane
    Morgan, John M.
    Jasani, Bharat
    Miller, Keith
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (01) : 157 - 162
  • [27] HER2 testing: evolution and update for a companion diagnostic assay
    Robbins, Charles J.
    Bates, Katherine M.
    Rimm, David L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025,
  • [28] HER2 In Situ Hybridization in Gastric and Gastroesophageal Adenocarcinoma: Comparison of Automated Dual ISH to FISH
    Grin, Andrea
    Brezden-Masley, Christine
    Bauer, Sharon
    Streutker, Catherine J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013, 21 (06) : 561 - 566
  • [29] Correlation of Immunohistochemistry for HER2 with Bright Field Dual ISH (DDISH) in Extramammary Paget Disease
    Cunnnings, D.
    Tubbs, R. R.
    Rowe, J. J.
    Lanigan, C.
    Billings, S. D.
    MODERN PATHOLOGY, 2012, 25 : 118A - 118A
  • [30] Correlation of Immunohistochemistry for HER2 with Bright Field Dual ISH (DDISH) in Extramammary Paget Disease
    Cummings, D.
    Tubbs, R. R.
    Rowe, J. J.
    Lanigan, C.
    Billings, S. D.
    LABORATORY INVESTIGATION, 2012, 92 : 118A - 118A
12345